News
Kiniksa Pharmaceuticals International, plc (KNSA) Earnings Expected to Grow: Should You Buy?
Wall Street expects a year-over-year increase in earnings on higher revenues when Kiniksa Pharmaceuticals International, plc (KNSA) reports results for the quarter ended December 2025. While this
Jazz Pharmaceuticals (JAZZ) Reports Next Week: Wall Street Expects Earnings Growth
The market expects Jazz Pharmaceuticals (JAZZ) to deliver a year-over-year increase in earnings on higher revenues when it reports results for the quarter ended December 2025. This widely-known
Par Petroleum (PARR) Earnings Expected to Grow: What to Know Ahead of Next Week's Release
Wall Street expects a year-over-year increase in earnings on lower revenues when Par Petroleum (PARR) reports results for the quarter ended December 2025. While this widely-known consensus outlook
MGE (MGEE) Earnings Expected to Grow: Should You Buy?
Wall Street expects a year-over-year increase in earnings on higher revenues when MGE (MGEE) reports results for the quarter ended December 2025. While this widely-known consensus outlook is
Analysts Estimate Matador Resources (MTDR) to Report a Decline in Earnings: What to Look Out for
The market expects Matador Resources (MTDR) to deliver a year-over-year decline in earnings on lower revenues when it reports results for the quarter ended December 2025. This widely-known consensus
Inogen (INGN) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release
Wall Street expects a year-over-year increase in earnings on higher revenues when Inogen (INGN) reports results for the quarter ended December 2025. While this widely-known consensus outlook is
Workday (WDAY) Earnings Expected to Grow: Should You Buy?
Wall Street expects a year-over-year increase in earnings on higher revenues when Workday (WDAY) reports results for the quarter ended January 2026. While this widely-known consensus outlook is
Earnings Preview: VERRA MOBILITY CORP (VRRM) Q4 Earnings Expected to Decline
Wall Street expects a year-over-year decline in earnings on higher revenues when VERRA MOBILITY CORP (VRRM) reports results for the quarter ended December 2025. While this widely-known consensus
Interparfums (IPAR) Expected to Beat Earnings Estimates: Should You Buy?
Interparfums (IPAR) is expected to deliver a year-over-year decline in earnings on higher revenues when it reports results for the quarter ended December 2025. This widely-known consensus outlook
Talos Energy (TALO) Expected to Beat Earnings Estimates: What to Know Ahead of Q4 Release
Wall Street expects a year-over-year decline in earnings on lower revenues when Talos Energy (TALO) reports results for the quarter ended December 2025. While this widely-known consensus outlook is
Analysts Estimate Portillo's Inc. (PTLO) to Report a Decline in Earnings: What to Look Out for
Portillo's Inc. (PTLO) is expected to deliver a year-over-year decline in earnings on higher revenues when it reports results for the quarter ended December 2025. This widely-known consensus
Earnings Preview: Supernus Pharmaceuticals (SUPN) Q4 Earnings Expected to Decline
Wall Street expects a year-over-year decline in earnings on higher revenues when Supernus Pharmaceuticals (SUPN) reports results for the quarter ended December 2025. While this widely-known
Tarsus Pharmaceuticals, Inc. (TARS) Expected to Beat Earnings Estimates: Can the Stock Move Higher?
Tarsus Pharmaceuticals, Inc. (TARS) is expected to deliver a year-over-year increase in earnings on higher revenues when it reports results for the quarter ended December 2025. This widely-known
Planet Fitness (PLNT) Earnings Expected to Grow: What to Know Ahead of Next Week's Release
The market expects Planet Fitness (PLNT) to deliver a year-over-year increase in earnings on higher revenues when it reports results for the quarter ended December 2025. This widely-known consensus
Earnings Preview: Harmony Biosciences Holdings, Inc. (HRMY) Q4 Earnings Expected to Decline
The market expects Harmony Biosciences Holdings, Inc. (HRMY) to deliver a year-over-year decline in earnings on higher revenues when it reports results for the quarter ended December 2025. This
Henry Schein (HSIC) Earnings Expected to Grow: Should You Buy?
Wall Street expects a year-over-year increase in earnings on higher revenues when Henry Schein (HSIC) reports results for the quarter ended December 2025. While this widely-known consensus outlook
Earnings Preview: International General Insurance Holdings Ltd. (IGIC) Q4 Earnings Expected to Decline
International General Insurance Holdings Ltd. (IGIC) is expected to deliver a year-over-year decline in earnings on higher revenues when it reports results for the quarter ended December 2025. This
Home Depot (HD) Expected to Beat Earnings Estimates: What to Know Ahead of Q4 Release
Wall Street expects a year-over-year decline in earnings on lower revenues when Home Depot (HD) reports results for the quarter ended January 2026. While this widely-known consensus outlook is
First Watch Restaurant Group, Inc. (FWRG) Earnings Expected to Grow: Should You Buy?
The market expects First Watch Restaurant Group, Inc. (FWRG) to deliver a year-over-year increase in earnings on higher revenues when it reports results for the quarter ended December 2025. This
First Solar (FSLR) Reports Next Week: Wall Street Expects Earnings Growth
Wall Street expects a year-over-year increase in earnings on higher revenues when First Solar (FSLR) reports results for the quarter ended December 2025. While this widely-known consensus outlook
Will Day One Biopharmaceuticals, Inc. (DAWN) Report Negative Earnings Next Week? What You Should Know
Wall Street expects a year-over-year increase in earnings on higher revenues when Day One Biopharmaceuticals, Inc. (DAWN) reports results for the quarter ended December 2025. While this
Gulfport Energy (GPOR) Reports Next Week: Wall Street Expects Earnings Growth
The market expects Gulfport Energy (GPOR) to deliver a year-over-year increase in earnings on higher revenues when it reports results for the quarter ended December 2025. This widely-known
Earnings Preview: Cytokinetics (CYTK) Q4 Earnings Expected to Decline
Cytokinetics (CYTK) is expected to deliver a year-over-year decline in earnings on lower revenues when it reports results for the quarter ended December 2025. This widely-known consensus outlook
Earnings Preview: Carlyle Secured Lending, Inc. (CGBD) Q4 Earnings Expected to Decline
Wall Street expects a year-over-year decline in earnings on higher revenues when Carlyle Secured Lending, Inc. (CGBD) reports results for the quarter ended December 2025. While this widely-known
CoStar Group (CSGP) Reports Next Week: Wall Street Expects Earnings Growth
Wall Street expects a year-over-year increase in earnings on higher revenues when CoStar Group (CSGP) reports results for the quarter ended December 2025. While this widely-known consensus outlook